famotidine has been researched along with Ascites in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Ascites: Accumulation or retention of free fluid within the peritoneal cavity.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Plasma data were subjected to non compartmental pharmacokinetic analysis." | 6.67 | Pharmacokinetics of famotidine in patients with cirrhosis and ascites. ( Baldit, C; Bannwarth, B; Begaud, B; Couzigou, P; Demotes-Mainard, F; Elouaer-Blanc, L; Vinçon, G, 1992) |
| " Plasma data were subjected to non compartmental pharmacokinetic analysis." | 2.67 | Pharmacokinetics of famotidine in patients with cirrhosis and ascites. ( Baldit, C; Bannwarth, B; Begaud, B; Couzigou, P; Demotes-Mainard, F; Elouaer-Blanc, L; Vinçon, G, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vinçon, G | 1 |
| Baldit, C | 1 |
| Couzigou, P | 1 |
| Demotes-Mainard, F | 1 |
| Elouaer-Blanc, L | 1 |
| Bannwarth, B | 1 |
| Begaud, B | 1 |
1 trial available for famotidine and Ascites
| Article | Year |
|---|---|
Pharmacokinetics of famotidine in patients with cirrhosis and ascites.
Topics: Administration, Oral; Adult; Ascites; Biological Availability; Famotidine; Female; Humans; Injection | 1992 |